doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: malaria

1 - 5 of 11 <<previous | next>>

Diseases results:

Infectious diseases
Psychosis
Systemic lupus erythematosus
Urticaria

Articles results:

Comparison Of Three Antimalarial Drug Combinations In Tanzania
Researchers from the London School of Hygiene and Tropical Medicine have evaluated the cost-effectiveness of the three alternative combinations of drugs now recommended for the treatment of malaria in East Africa. They found that the drug combination that was the most expensive in the short term was in fact the most cost-effective, because its superior performance in curing malaria reduced the need for further treatment.Resistance to malaria drugs is extremely common.


Industry Affirms Support For Innovative Finance Mechanisms For Vaccines
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) welcomes the forthcoming presentation of the inaugural bond for the International Finance Facility for Immunization (IFFIm), to improve developing countries' access to under-used and new vaccines. IFFIm and innovative finance mechanisms such as Advance Market Commitments (AMCs)* reflect growing international recognition of the importance of disease prevention in general and vaccines in particular.


IFPMA Welcomes New WHO Director General
The International Federation of Pharmaceutical Manufacturers Associations (IFPMA) warmly welcomes the nomination by the World Health Organization Executive Board of Dr. Margaret Chan for the post of Director-General of the WHO. Subject to approval by the full WHO membership, Dr. Chan will succeed Dr. Jong Wook Lee, who died so tragically at the beginning of the 59th World Health Assembly in Geneva in May 2006.


Putting People First To Link Health And Biodiversity Conservation
By training professionals in high-biodiversity regions to advance the drug discovery process in-country, a novel program drives drug discovery costs down as it promotes tropical biodiversity conservation. An international team describes a successful test of the program in Panama in the December, 2006 issue of BioScience."Instead of sending samples to the U.S.


Two Lead Drug Development Programs Of MuriGen Therapeutics To Be Enhanced By AUD$5 Million Investment By Starfish Ventures
MuriGen Therapeutics, a drug discovery and development company originally spun-out from the Walter and Eliza Hall Institute of Medical Research, has announced the successful completion of a AUD$5 million investment by leading Australian venture capital firm, Starfish Ventures. Dr Nick Samaras, MuriGenâ¬"s Chief Executive Officer, said, â¬?We are very pleased to have attracted a high quality investor such as Starfish Ventures.




1 - 5 of 11 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.